Lindsey George: Understanding the Enhanced Activity of FVIII Aurora
Lindsey George, Assistant Professor of Pediatrics at University of Pennsylvania, Director of Clinical In Vivo Gene Therapy at Children’s Hospital of Philadelphia, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Blood, adding:
”Congratulations Johnathan Morris!
This manuscript describes the underlying mechanism of FVIII Aurora (FVIII-R571S), which has 10–20-fold higher affinity for FIXa over FVIII-WT and FIXa-dependent reduced inactivation by A2-domain dissociation and APC cleavage.”
Title: Factor VIII Aurora: A Naturally Occurring Gain of Function FVIII Variant with Enhanced FIXa Affinity
Authors: Johnathan J. Morris, Robert J Davidson, Connor T. Watson, Lindsey A. George
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 18, 2026, 18:00Karen Schreiber: Advancing Thrombosis Epidemiology Through Global Collaboration at ISTH 2026
-
Jul 18, 2026, 17:34Living With ITP – A New Resource for Navigating Your Diagnosis – ITP Support Association
-
Jul 18, 2026, 17:34Mona Alfaraj: It Was a Hot Week Attending ISTH 2026 Congress in Paris
-
Jul 18, 2026, 17:26Shernan Holtan: Latest Publication on PTCy
-
Jul 18, 2026, 17:20Doaa EL Demerdash: Connecting the Global ITP Community at ISTH 2026
-
Jul 18, 2026, 16:58Isabella Presch: Innovative Trial Designs for Rare Pediatric Studies
-
Jul 18, 2026, 16:36Caitlin Schneider: Research, Collaboration, and New Beginnings at ISTH 2026
-
Jul 18, 2026, 16:23Panagiota Tsiatsiou: Honored to Present Our Research at the ISTH 2026 Congress in Paris
-
Jul 18, 2026, 16:03Robert Tadevosyan: A Week of Science, Collaboration, and Growth at ISTH 2026